Top 50 Pharmaceutical Companies by R&D in 2013

Written by on December 10, 2013 in Drug Discovery, Engagement & Communications, Featured on app with 1 Comment

Top 50 Pharmaceutical Companies by Research and development spending in 2013

The Pharmaceutical and Biotechnology industries continues to dominate the world’s R&D expenditure according to the 2013 EU Industrial R&D Scoreboard. Whilst the top 5 spots may be taken up by automobile, electronics, and software companies, it is pharmaceutical companies who dominate the second half of the top 10. With the top five companies spending accounting for a third of the €88,492.2 million 2013 spending on research and development by the top 50 pharmaceutical companies.

The Scoreboard takes data from 2000 companies worldwide (527 from the EU) and arranges these companies into a list based on their R&D spending over the 2012/2013 financial year. The data from the 2013 scoreboard shows that R&D spending amongst the top 50 is up by $4319.4 million compared to 2012.

If you enjoy this list, you may also be interested in the 2012 Top 50 R&D Spenders in Pharma

The Top 50 Pharmaceutical Companies by Research and Development Investment:

Pharma Rank World Rank Company Country $ million
1 6 ROCHE Switzerland 7007.8
2 7 NOVARTIS Switzerland 6922.8
3 8 MERCK US USA 5995.9
4 9 JOHNSON & JOHNSON USA 5809.5
5 10 PFIZER USA 5740.5
6 15 SANOFI-AVENTIS France 4909.0
7 20 GLAXOSMITHKLINE UK 4229.0
8 26 ELI LILLY USA 4000.4
9 33 ASTRAZENECA UK 3375.0
10 35 ABBOTT LABORATORIES USA 3275.9
11 36 BAYER Germany 3182.0
12 40 BRISTOL-MYERS SQUIBB USA 2851.3
13 41 TAKEDA PHARMACEUTICAL Japan 2839.8
14 42 BOEHRINGER INGELHEIM Germany 2795.0
15 47 AMGEN USA 2561.8
16 67 OTSUKA Japan 1684.5
17 68 DAIICHI SANKYO Japan 1602.9
18 69 ASTELLAS PHARMA Japan 1593.4
19 72 MERCK DE Germany 1511.3
20 78 NOVO NORDISK Denmark 1397.4
21 81 GILEAD SCIENCES USA 1333.9
22 87 CELGENE USA 1205.8
23 107 EISAI Japan 1054.1
24 110 BIOGEN IDEC USA 1011.8
25 114 TEVA PHARMACEUTICAL INDUSTRIES Israel 972.4
26 126 SERVIER France 862.0
27 145 UCB Belgium 782.0
28 148 ALLERGAN USA 750.0
29 161 FOREST LABORATORIES USA 676.5
30 165 SHIRE UK 660.8
31 177 VERTEX PHARMACEUTICALS USA 571.5
32 214 SHIONOGI Japan 464.3
33 245 ONO PHARMACEUTICAL Japan 397.9
34 253 ACTELION Switzerland 380.8
35 279 H LUNDBECK Denmark 338.4
36 298 ZOETIS USA 310.0
37 302 HOSPIRA USA 304.8
38 303 WATSON PHARMACEUTICALS USA 304.5
39 308 MYLAN USA 294.8
40 329 CSL Australia 280.0
41 334 IPSEN France 275.3
42 345 LIFE TECHNOLOGIES USA 259.1
43 356 GRUNENTHAL Germany 251.0
44 363 ONYX PHARMACEUTICALS USA 246.5
45 379 BIOMARIN PHARMACEUTICAL USA 229.1
46 389 BIOMERIEUX France 218.6
47 406 TAISHO PHARMACEUTICAL Japan 204.3
48 415 CHIESI FARMACEUTICI Italy 198.0
49 424 NOVOZYMES Denmark 193.7
50 459 ILLUMINA USA 175.1

Tags: , , , , , , , ,

About the Author

About the Author: Despite holding a degree in philosophy, I've a taste for the scientific and the experimental. With interests in innovation, experimentation and business strategy within the life sciences you will find me writing for Vaccine Nation, Total Orphan Drugs, and Total BioPharma .

Subscribe

If you enjoyed this article, subscribe now to receive more just like it.

1 Reader Comment

Trackback URL Comments RSS Feed

Sites That Link to this Post

  1. Top 50 Pharmaceutical Companies by R&D in 2... | December 10, 2013

Leave a Reply

Your email address will not be published. Required fields are marked *

Top
Geolocation